We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Closes Overseas Plants in Cost-Cutting Effort
Novartis Closes Overseas Plants in Cost-Cutting Effort
Switzerland’s Novartis is shuttering several of its research operations in Switzerland and China, eliminating 175 jobs, in an effort to centralize control of its drug discovery programs and curb costs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor